BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1486046)

  • 1. Cytogenetic and molecular remission in a case of acute myeloid leukaemia(AML) with inversion of chromosome 16 (Inv(16)) and Philadelphia chromosome (Ph).
    Preudhomme C; Lai JL; Plantier I; Demory JL; Zandecki M; Fenaux P
    Br J Haematol; 1992 Nov; 82(3):623-6. PubMed ID: 1486046
    [No Abstract]   [Full Text] [Related]  

  • 2. Early transformation to acute myeloblastic leukaemia with the acquisition of inv(16) in Ph positive chronic granulocytic leukaemia.
    Myint H; Ross FM; Hall JL; Hamblin TJ
    Leuk Res; 1997 May; 21(5):473-4. PubMed ID: 9225078
    [No Abstract]   [Full Text] [Related]  

  • 3. Inversion of chromosome 16 in accelerated phase of chronic myeloid leukaemia: report of a case and review of the literature.
    Colović M; Janković G; Bila J; Djordjević V; Wiernik PH
    Med Oncol; 1998 Sep; 15(3):199-201. PubMed ID: 9819797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults.
    Min GJ; Kim HJ; Yoon JH; Kwak DH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1621-1628. PubMed ID: 29698793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of inv(8)(p11q13) in AML with erythrophagocytosis: a new cytogenetic variant.
    Coulthard S; Chase A; Orchard K; Watmore A; Vora A; Goldman JM; Swirsky DM
    Br J Haematol; 1998 Mar; 100(3):561-3. PubMed ID: 9504640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inv(16) in Ph-negative cells of a chronic myelogenous leukemia patient after imatinib treatment.
    Rowe LR; Brothman AR; Nibley WE; Gaffney MR; Chen Z
    Cancer Genet Cytogenet; 2007 Apr; 174(1):54-6. PubMed ID: 17350467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of a case of Philadelphia chromosome-positive acute myeloid leukemia.
    Yoshida A; Kishi S; Kita K; Kamada N; Nakamura T; Ueda T
    Anticancer Res; 1997; 17(1B):625-8. PubMed ID: 9066590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Philadelphia chromosome as a secondary abnormality in inv(3)(q21q26) acute myeloid leukemia at diagnosis: confirmation of p190 BCR-ABL mRNA by real-time quantitative polymerase chain reaction.
    Han JY; Theil KS
    Cancer Genet Cytogenet; 2006 Feb; 165(1):70-4. PubMed ID: 16490599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inversion of chromosome 16 with the Philadelphia chromosome in acute myelomonocytic leukemia with eosinophilia. Report of two cases.
    Secker-Walker LM; Morgan GJ; Min T; Swansbury GJ; Craig J; Yamada T; Desalvo L; Medina JW; Chowdhury V; Donahue RP
    Cancer Genet Cytogenet; 1992 Jan; 58(1):29-34. PubMed ID: 1728947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.
    Marlton P; Keating M; Kantarjian H; Pierce S; O'Brien S; Freireich EJ; Estey E
    Leukemia; 1995 Jun; 9(6):965-71. PubMed ID: 7596186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of Inv(16)(p13q22) in a blast crisis of chronic myeloid leukemia: case report.
    Oñate G; Blanco ML; Pratcorona M
    Med Clin (Barc); 2019 May; 152(10):419-420. PubMed ID: 30392698
    [No Abstract]   [Full Text] [Related]  

  • 12. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
    Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y
    Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature.
    Zhang XH; Zhang R; Li Y
    Leuk Res; 2010 Jul; 34(7):958-61. PubMed ID: 20116851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinib.
    Jentsch-Ullrich K; Pelz AF; Braun H; Koenigsmann M; Mohren M; Wieacker P; Franke A
    Haematologica; 2004 May; 89(5):ECR15. PubMed ID: 15136244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
    Buonamici S; Ottaviani E; Testoni N; Montefusco V; Visani G; Bonifazi F; Amabile M; Terragna C; Ruggeri D; Piccaluga PP; Isidori A; Malagola M; Baccarani M; Tura S; Martinelli G
    Blood; 2002 Jan; 99(2):443-9. PubMed ID: 11781223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia.
    Enright H; Weisdorf D; Peterson L; Rydell RE; Kaplan ME; Arthur DC
    Leukemia; 1992 May; 6(5):381-4. PubMed ID: 1593903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Philadelphia chromosome-positive acute myeloid leukemia with tetraploidy.
    Yamaguchi H; Inokuchi K; Yokomizo E; Miyata J; Watanabe A; Inami M; Tajika K; Dan K
    Int J Hematol; 2002 Jan; 75(1):63-6. PubMed ID: 11843293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome.
    Isoda A; Nakahashi H; Hoshino T; Mitsui T; Yoshida Y
    Am J Hematol; 2007 Jun; 82(6):501-2. PubMed ID: 17301971
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia.
    Freireich EJ; Cork A; Stass SA; McCredie KB; Keating MJ; Estey EH; Kantarjian HM; Trujillo JM
    Leukemia; 1992 Jun; 6(6):500-6. PubMed ID: 1602788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact.
    Döhner K; Schlenk RF; van der Reijden BA; Döhner H
    Leukemia; 2000 Jun; 14(6):1154. PubMed ID: 10865983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.